SuperworthOptimizeRx shares outstanding OPRX
Diluted shares outstanding, averaged over each quarter, from 2012.
- Latest quarter, to Jun 30, 2026
- 18.8M
- On a year earlier
- −1.2%
- fewer shares
OptimizeRx had 18.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 1.2% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 18.9M | +3% |
| FY2024 | 18.4M | +4% |
| FY2023 | 17.8M | +4% |
| FY2022 | 17.2M | −6% |
| FY2021 | 18.3M | +21% |
| FY2020 | 15.1M | +4% |
| FY2019 | 14.5M | +35% |
| FY2018 | 10.8M | +11% |
| FY2017 | 9.8M | −5% |
| FY2016 | 10.2M | +31% |
| FY2013 | 7.8M | −11% |
| FY2012 | 8.7M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 18.8M | −1% | |
| Q1 FY26 | 18.8M | +2% | |
| Q4 FY25 | 18.9M | +3% | |
| Q3 FY25 | 19.5M | +6% | |
| Q2 FY25 | 19M | +4% | |
| Q1 FY25 | 18.5M | +2% | |
| Q4 FY24 | 18.4M | +4% | |
| Q3 FY24 | 18.3M | +10% | |
| Q2 FY24 | 18.3M | +7% | |
| Q1 FY24 | 18.2M | +6% | |
| Q4 FY23 | 17.8M | +4% | |
| Q3 FY23 | 16.6M | −7% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on OptimizeRx
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.